Publikationen (52) Publikationen, an denen Forscher/innen teilgenommen haben

2018

  1. A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered Questionnaires

    Clinical Pharmacology and Therapeutics, Vol. 103, Núm. 6, pp. 1074-1082

  2. A case-control study of non-AIDS-defining cancers in a prospective cohort of HIV-infected patients

    Medicina Clinica, Vol. 150, Núm. 8, pp. 291-296

  3. Aging and the evolution of comorbidities among HIV-positive individuals in a European cohort

    AIDS (London, England), Vol. 32, Núm. 16, pp. 2405-2416

  4. Barriers to health care services for migrants living with HIV in Spain

    European Journal of Public Health, Vol. 28, Núm. 3, pp. 451-457

  5. Bin-CE: A comprehensive web application to decide upon the best set of outcomes to be combined in a binary composite endpoint

    PLoS ONE, Vol. 13, Núm. 12

  6. Cerebrovascular Events in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study

    Arthritis Care and Research, Vol. 70, Núm. 10, pp. 1478-1487

  7. Cognitive impairment in patients with neuropsychiatric and non-neuropsychiatric systemic lupus erythematosus: A systematic review and meta-analysis

    Journal of the International Neuropsychological Society, Vol. 24, Núm. 6, pp. 629-639

  8. Combined mepacrine–hydroxychloroquine treatment in patients with systemic lupus erythematosus and refractory cutaneous and articular activity

    Lupus, Vol. 27, Núm. 10, pp. 1718-1722

  9. Computerized registry of patients with hemorrhagic hereditary telangiectasia (RiHHTa Registry) in Spain: Objectives, methods, and preliminary results

    Revista Clinica Espanola, Vol. 218, Núm. 9, pp. 468-476

  10. Correlates of neurocognitive functions in individuals at ultra-high risk for psychosis - A 6-month follow-up study

    Psychiatry Research, Vol. 268, pp. 1-7

  11. Costs and cost-efficacy analysis of the 2017 GESIDA/Spanish National AIDS Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 36, Núm. 5, pp. 268-276

  12. Detection of spleen, kidney and liver infarcts by abdominal computed tomography does not affect the outcome in patients with left-side infective endocarditis

    Medicine (United States), Vol. 97, Núm. 33

  13. Dysregulation of the immune system in HIV/HCV-coinfected patients according to liver stiffness status

    Cells, Vol. 7, Núm. 11

  14. Economic Evaluation of Lupus Nephritis in the Systemic Lupus International Collaborating Clinics Inception Cohort Using a Multistate Model Approach

    Arthritis Care and Research, Vol. 70, Núm. 9, pp. 1294-1302

  15. Efficacy and safety of switching from boosted protease inhibitors plus emtricitabine and tenofovir disoproxil fumarate regimens to single-tablet darunavir, cobicistat, emtricitabine, and tenofovir alafenamide at 48 weeks in adults with virologically suppressed HIV-1 (EMERALD): a phase 3, randomised, non-inferiority trial

    The Lancet HIV, Vol. 5, Núm. 1, pp. e23-e34

  16. Efficacy of Idursulfase therapy in patients with Mucopolysaccharidosis type II who initiated enzyme replacement therapy in adult age. A systematic review of the literature

    Molecular Genetics and Metabolism, Vol. 124, Núm. 3, pp. 216-227

  17. Erysipelas or cellulitis with a prosthetic joint <em>in situ</em>

    Journal of Bone and Joint Infection, Vol. 3, Núm. 4, pp. 222-225

  18. Factors leading to the loss of natural elite control of HIV-1 infection

    Journal of Virology, Vol. 92, Núm. 5

  19. Fever induced by mesalazine

    Gastroenterologia y Hepatologia, Vol. 41, Núm. 4, pp. 261-262

  20. Gentamicin may have no effect on mortality of staphylococcal prosthetic valve endocarditis

    Journal of Infection and Chemotherapy, Vol. 24, Núm. 7, pp. 555-562